Stimcell Energetics (STME) Net Equity Issued and Repurchased (2017 - 2021)
Stimcell Energetics' (STME) quarterly Net Equity Issued and Repurchased came in at $160000.0 in Q3 2021, down 4.19% year-on-year from $167000.0 in Q3 2020, and up 300.0% quarter-over-quarter from $40000.0 in Q2 2021.
Stimcell Energetics (STME) Net Equity Issued and Repurchased (2017 - 2021) Analysis & Trends
Stimcell Energetics' Net Equity Issued and Repurchased history runs 4 years deep, the most recent figure standing at $160000.0 for Q3 2021.
- On a quarterly basis, Net Equity Issued and Repurchased fell 4.19% year-over-year to $160000.0 in Q3 2021; TTM through May 2022 was $160000.0, a 22.71% decrease from a year earlier, with the FY2024 full-year figure at $75000.0, changed N/A from the prior year.
- Net Equity Issued and Repurchased improved to $160000.0 in Q3 2021 per STME's latest filing, from $40000.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $486000.0 in Q3 2019 and bottomed at -$167000.0 in Q4 2020.
- The 4-year median for Net Equity Issued and Repurchased is $160000.0 (2021), against an average of $144777.8.
- Across the five-year window, Net Equity Issued and Repurchased sank 65.64% in 2020 and fell 4.19% in 2021, its largest moves.
- Year by year, Net Equity Issued and Repurchased stood at $20000.0 in 2017, then soared by 2330.0% to $486000.0 in 2019, then plunged by 134.36% to -$167000.0 in 2020, then jumped by 195.81% to $160000.0 in 2021.
- Per Business Quant, the three latest STME Net Equity Issued and Repurchased figures stand at $160000.0 (Q3 2021), $40000.0 (Q2 2021), and $167000.0 (Q1 2021).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 12.70 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Aug 31, 2021 | 160,000.00 |
| Aug 31, 2021 | 160,000.00 |
| May 31, 2021 | 40,000.00 |
| May 31, 2021 | 40,000.00 |
| Feb 28, 2021 | 167,000.00 |
| Feb 28, 2021 | 167,000.00 |
| Nov 30, 2020 | -167,000.00 |
| Nov 30, 2020 | -167,000.00 |
| Aug 31, 2020 | 167,000.00 |
| Aug 31, 2020 | 167,000.00 |
| May 31, 2020 | 80,000.00 |
| May 31, 2020 | 80,000.00 |
| Aug 31, 2019 | 486,000.00 |
| Aug 31, 2019 | 486,000.00 |
| Nov 30, 2017 | 20,000.00 |
| Nov 30, 2017 | 20,000.00 |
| Aug 31, 2017 | 350,000.00 |
| Aug 31, 2017 | 350,000.00 |